GPT and metabolic dysfunction-associated steatohepatitis: In NASH models, knockdown of circRNA-002581 reduced lipid accumulation, ALT and AST levels, hydrogen peroxide (H2O2), pro-inflammatory cytokines, and apoptosis, while increasing ATP levels—suggesting circRNA-002581 as a potential therapeutic target for NASH (Figure 4) [135].